Vantage Market Research
Jan 29, 2025
According to analysts at Vantage Market Research, the Global Minimally invasive surgery Market size is worth USD 78.5 Billion in 2024 and is projected to reach USD 432.3 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 16.8% from 2024 to 2035. Key trends of market include rise of robotic-assisted surgeries, advancements in imaging technologies, growing preference for outpatient procedures, and development of smaller surgical instruments.
Market Overview
Laparoscopic procedures are less invasive and offer cost savings in terms of pre- and post-operative care, as well as shorter hospital stays. These surgeries result in reduced blood loss, fewer complications after surgery, and quicker recovery times for patients. Furthermore, health insurance providers in some countries are increasingly covering minimally invasive surgeries. Physicians prefer these procedures over traditional open surgeries due to their cost-saving potential for hospitals.
Emerging markets present significant growth opportunities for minimally invasive surgery market. Factors such as lower regulatory barriers, improvements in healthcare infrastructure, expanding patient populations, rising healthcare spending, increasing disposable incomes, and a growing aging demographic are driving this growth. The Asia Pacific region, in particular, offers a more adaptable and business-friendly environment compared to developed countries. This, combined with increasing competition in mature markets, is prompting leading players in the minimally invasive surgery market to focus on emerging countries.
Arthrex Launches TheNanoExperience.com to Highlight Nano Arthroscopy Benefits
- Arthrex has recently launched TheNanoExperience.com, a new resource designed for patients that highlights the science behind Nano arthroscopy and its benefits. This cutting-edge orthopedic procedure is minimally invasive, offering the potential for a quicker recovery and less pain, allowing patients to return to their activities faster
Key Takeaways from the Report
- In 2024, North America dominated the market with 40.5% of market share. The market is driven by rising demand for minimally invasive procedures, and the presence of leading healthcare providers and medical device manufacturers.
- Based on the Product, the Surgical Devices category accounted for significant market share of 53.5% in 2024. The segment is driven by advancements in technology, an increase in the usage of minimally invasive procedures, and the demand for affordable medical solutions
- In 2024, by Application, Neurological surgery dominated the largest market share. The segment is driven by advancements in surgical techniques, the increasing prevalence of neurological disorders, and the rising demand for less invasive, more precise procedures
- By End User, Hospitals, clinics, and ablation centers dominated the largest market share. The segment is driven by increasing demand for efficient, cost-effective surgical procedures that reduce recovery times and improve patient outcomes
Top Companies
- King Fahd Medical City
- Mount Elizabeth Hospital
- Manipal Health Enterprises Pvt Ltd
- The Johns Hopkins Hospital
- Circle Health Ltd
- Stanford Healthcare
- Singapore General Hospital Ltd
- Apollo Hospitals Enterprise Ltd
- The General Hospital Corporation
- Bedfordshire Hospitals
Report Coverage
Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.
Latest News
Medtronic Secures CE Mark Approval for Affera Mapping and Ablation System
- In 2023, Medtronic's Affera Mapping and Ablation System received CE Mark approval for the treatment of atrial arrhythmias